Clearmind Medicine Inc.
CMND · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $214 | $5 | $6 | $6 |
| - Cash | $3 | $4 | $6 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $210 | $1 | $0 | -$1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.25 | -6.4 | -9.6 | -8.4 |
| % Growth | 96.1% | 33.3% | -14.3% | – |
| Operating Cash Flow | -$2 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$1 | -$1 |